Enanta Pharmaceuticals (ENTA) Current Taxes (2014 - 2018)
Enanta Pharmaceuticals' (ENTA) quarterly Current Taxes came in at $5.9 million in Q4 2018, down 42.89% YoY from $10.3 million in Q4 2017, and up 322.05% on a QoQ basis from $1.4 million in Q3 2018.
Enanta Pharmaceuticals (ENTA) Current Taxes (2014 - 2018) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 5 years of Current Taxes data on file, last reported at $5.9 million in Q4 2018.
- Quarterly Current Taxes fell 42.89% year-over-year to $5.9 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $5.9 million (down 42.89% YoY) and the FY2018 annual result came in at $1.4 million, down 85.07% from the prior year.
- Current Taxes advanced to $5.9 million in Q4 2018, from $1.4 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $16.9 million in Q4 2014 to a low of $1.2 million in Q3 2015.
- A 5-year average of $6.8 million and a median of $5.6 million in 2018 frame the typical range for Current Taxes.
- Annual changes were most pronounced in 2016 — Current Taxes soared 31.99% — and 2018, when it plunged 85.07%.
- Tracing ENTA's Current Taxes over 5 years: stood at $16.9 million in 2014, then slumped by 70.76% to $4.9 million in 2015, then slumped by 40.45% to $2.9 million in 2016, then soared by 248.64% to $10.3 million in 2017, then plunged by 42.89% to $5.9 million in 2018.
- The last three Current Taxes figures came in at $5.9 million (Q4 2018), $1.4 million (Q3 2018), and $5.4 million (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 5.86 Mn |
| Sep 30, 2018 | 1.39 Mn |
| Mar 31, 2018 | 5.38 Mn |
| Dec 31, 2017 | 10.26 Mn |
| Sep 30, 2017 | 9.30 Mn |
| Jun 30, 2016 | 2.94 Mn |
| Mar 31, 2016 | 6.78 Mn |
| Dec 31, 2015 | 4.94 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Jun 30, 2015 | 2.23 Mn |
| Mar 31, 2015 | 14.54 Mn |
| Dec 31, 2014 | 16.90 Mn |